↓ Skip to main content

Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis

Overview of attention for article published in Orphanet Journal of Rare Diseases, October 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
googleplus
1 Google+ user

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis
Published in
Orphanet Journal of Rare Diseases, October 2013
DOI 10.1186/1750-1172-8-167
Pubmed ID
Authors

Johannes Pfeil, Stefan Listl, Georg F Hoffmann, Stefan Kölker, Martin Lindner, Peter Burgard

Abstract

Glutaric aciduria type I (GA-I) is a rare metabolic disorder caused by inherited deficiency of glutaryl-CoA dehydrogenase. Despite high prognostic relevance of early diagnosis and start of metabolic treatment as well as an additional cost saving potential later in life, only a limited number of countries recommend newborn screening for GA-I. So far only limited data is available enabling health care decision makers to evaluate whether investing into GA-I screening represents value for money. The aim of our study was therefore to assess the cost-effectiveness of newborn screening for GA-I by tandem mass spectrometry (MS/MS) compared to a scenario where GA-I is not included in the MS/MS screening panel.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 55 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 20%
Student > Master 9 16%
Student > Bachelor 9 16%
Researcher 6 11%
Student > Doctoral Student 4 7%
Other 10 18%
Unknown 7 13%
Readers by discipline Count As %
Medicine and Dentistry 26 46%
Biochemistry, Genetics and Molecular Biology 6 11%
Economics, Econometrics and Finance 3 5%
Psychology 3 5%
Agricultural and Biological Sciences 2 4%
Other 6 11%
Unknown 10 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2013.
All research outputs
#12,885,552
of 22,727,570 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,249
of 2,604 outputs
Outputs of similar age
#107,104
of 211,883 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#16
of 34 outputs
Altmetric has tracked 22,727,570 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,604 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,883 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.